NCT01041235 Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies Status COMPLETED Phase PHASE1
NCT01017731 Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes Status COMPLETED Phase PHASE2
NCT00982657 A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma Status TERMINATED Phase PHASE2
NCT00968916 Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 in Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT00927966 RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms Status COMPLETED Phase PHASE1
NCT00921336 Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid Tumor Status COMPLETED Phase PHASE1
NCT00920868 XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib Status COMPLETED Phase PHASE1
NCT00920595 Study of CEP-9722 as Single-Agent Therapy and as Combination Therapy With Temozolomide in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00898027 Effect of Epidermal Growth Factor Receptor Inhibitors on Magnesium Homeostasis in Patients With Cancer Status TERMINATED Phase N/A
NCT00896662 Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202 Status COMPLETED Phase N/A
NCT00894049 A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation Status COMPLETED Phase PHASE2
NCT00888108 Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Combination With Standard and Weekly Regimens of Docetaxel in Subjects With Cancer Status COMPLETED Phase PHASE1
NCT00867295 Effectiveness of Antibiotic Prophylaxis for Totally Implantable Venous Access Device Status COMPLETED Phase PHASE3
NCT00840190 A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies Status COMPLETED Phase PHASE1